Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649)

Autor: Stian Knappskog, Lb, Gansmo, Dibirova K, Metspalu A, Cybulski C, Peterlongo P, Aaltonen L, Vatten L, Romundstad P, Hveem K, Devilee P, Gd, Evans, Lin D, Van Camp G, Vg, Manolopoulos, Osorio A, Milani L, Ozcelik T, Zalloua P, Mouzaya F

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::67216d56d718a8acd7e631a283975cfb
http://europepmc.org/abstract/med/25327560

Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer.

Autor: Gansmo LB; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, 5021, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Sofiyeva N; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, 5021, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Bjørnslett M; Department of Molecular Oncology, Oslo University Hospital Radium Hospitalet, Oslo, Norway.; Institute for Cancer Research, University of Oslo, Oslo, Norway., Romundstad P; Department of Public Health, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Hveem K; K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Vatten L; Department of Public Health, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Dørum A; Department of Gynecologic Oncology, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway., Lønning PE; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, 5021, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Knappskog S; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, 5021, Bergen, Norway. stian.knappskog@uib.no.; Department of Oncology, Haukeland University Hospital, Bergen, Norway. stian.knappskog@uib.no.

Publikováno v: Scientific reports [Sci Rep] 2021 Dec 06; Vol. 11 (1), pp. 23463. Date of Electronic Publication: 2021 Dec 06.

Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer.

Autor: Helwa R; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Gansmo LB; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Bjørnslett M; Department of Molecular Oncology, Oslo University Hospital Radium Hospitalet, Oslo, Norway.; Institute for Cancer Research, University of Oslo, Oslo, Norway., Halle MK; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway., Werner HMJ; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway., Romundstad P; Department of Public Health, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Hveem K; K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Vatten L; Department of Public Health, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Dørum A; Department of Gynecologic Oncology, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway., Lønning PE; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Knappskog S; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway.

Publikováno v: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals [Biomarkers] 2021 Jun; Vol. 26 (4), pp. 302-308. Date of Electronic Publication: 2021 Feb 28.

The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells.

Autor: Huun J; Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway., Gansmo LB; Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway., Mannsåker B; Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Iversen GT; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Sommerfelt-Pettersen J; Joint Medical Services, Norwegian Armed Forces, Sessvollmoen, Norway., Øvrebø JI; Department of Biology, University of Bergen, Bergen, Norway., Lønning PE; Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Knappskog S; Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. Electronic address: stian.knappskog@uib.no.

Publikováno v: Translational oncology [Transl Oncol] 2017 Oct; Vol. 10 (5), pp. 806-817. Date of Electronic Publication: 2017 Aug 29.

Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer.

Autor: Yang S; a Department of Cancer Biology , Metastasis Research Center, University of Texas MD Anderson Cancer Center , Houston , TX , USA., Che SP; a Department of Cancer Biology , Metastasis Research Center, University of Texas MD Anderson Cancer Center , Houston , TX , USA., Kurywchak P; a Department of Cancer Biology , Metastasis Research Center, University of Texas MD Anderson Cancer Center , Houston , TX , USA., Tavormina JL; a Department of Cancer Biology , Metastasis Research Center, University of Texas MD Anderson Cancer Center , Houston , TX , USA., Gansmo LB; a Department of Cancer Biology , Metastasis Research Center, University of Texas MD Anderson Cancer Center , Houston , TX , USA., Correa de Sampaio P; a Department of Cancer Biology , Metastasis Research Center, University of Texas MD Anderson Cancer Center , Houston , TX , USA., Tachezy M; b Department of General , Visceral and Thoracic Surgery, University Medical Center of Hamburg-Eppendorf , Hamburg , Germany., Bockhorn M; b Department of General , Visceral and Thoracic Surgery, University Medical Center of Hamburg-Eppendorf , Hamburg , Germany., Gebauer F; b Department of General , Visceral and Thoracic Surgery, University Medical Center of Hamburg-Eppendorf , Hamburg , Germany., Haltom AR; a Department of Cancer Biology , Metastasis Research Center, University of Texas MD Anderson Cancer Center , Houston , TX , USA., Melo SA; c Instituto de Investigação e Inovação em Saúde, Universidade do Porto , Porto , Portugal (I3S).; d Institute of Pathology and Molecular Immunology of the University of Porto (IPATIMUP) , Porto , Portugal., LeBleu VS; a Department of Cancer Biology , Metastasis Research Center, University of Texas MD Anderson Cancer Center , Houston , TX , USA., Kalluri R; a Department of Cancer Biology , Metastasis Research Center, University of Texas MD Anderson Cancer Center , Houston , TX , USA.

Publikováno v: Cancer biology & therapy [Cancer Biol Ther] 2017 Mar 04; Vol. 18 (3), pp. 158-165. Date of Electronic Publication: 2017 Jan 25.